SynthesisAlimentary pharmacology & therapeutics2026
Meta-Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease.
Synthesis in Alimentary pharmacology & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Listening to the Body: Interoceptive Awareness and Eating Disorder Vulnerability in Adolescents with Inflammatory Bowel Diseases.Children (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsDisentangling whether disordered eating is a cause, consequence or manifestation of inflammatory bowel disease (IBD) symptoms remains a challenge. We conducted an updated systematic review and the first meta-analysis to estimate the prevalence of eating disorders in individuals with IBD.
methodsWe systematically searched MEDLINE, Embase and PsycINFO from inception to 28 October 2025, for original observational studies reporting the prevalence of at least one eating disorder in an IBD population. Pooled prevalence estimates were calculated using random-effects models and stratified by IBD type, sex, age and assessment method. Between-study heterogeneity was assessed using Q and I
resultsTwenty-three studies were included. Prevalence estimates varied substantially depending on how eating disorders were assessed. Studies using self-report questionnaires yielded a pooled prevalence of 13.60% (95% CI = 9.86%-17.81%; I
conclusionsEating disorders are prevalent among individuals with IBD, particularly avoidant/restrictive types. These findings highlight the need for improved screening and greater clinical awareness to better detect and manage disordered eating in the IBD population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.